Literature DB >> 12617233

The hitch stitch: an obsolete neurosurgical technique?

O B C Swayne1, B M Horner, N L Dorward.   

Abstract

The objective was to assess the efficacy of dural tenting sutures as a prophylactic measure against extradural haemorrhage following craniotomy. A comparison was made of postoperative extradural haemorrhage between a surgeon always using tenting sutures and a surgeon who never uses them. The subjects consisted of 130 adult patients, 44 with postoperative scans, with normal blood coagulation who underwent elective supratentorial craniotomy (September 1998 to December 2000). Outcome measures were haematoma volume and midline shift as measured on CT and reoperation due to extradural haematoma. The group using tenting sutures had larger median extradural haematoma (2.5 vs 2.0 ml) and midline shift (3 vs 0 mm) than the omitting group. These differences were not significant (P = 0.74 and 0.84). Reoperation due to extradural haemorrhage occurred in 3.6% of the group using tenting sutures and in 0% of the group omitting them. Prophylactic dural tenting sutures do not reduce the size of extradural haematomas in this study. A prospective, randomized trial is needed to eliminate surgeon bias.

Entities:  

Mesh:

Year:  2002        PMID: 12617233

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  2 in total

1.  Necessity of dural tenting sutures in modern neurosurgery: protocol for a systematic review.

Authors:  Łukasz Przepiórka; Przemysław Kunert; Jarosław Żyłkowski; Jan Fortuniak; Patrycja Larysz; Dariusz Szczepanek; Karol Wiśniewski; Dariusz Jaskólski; Piotr Ładziński; Radosław Rola; Tomasz Trojanowski; Andrzej Marchel
Journal:  BMJ Open       Date:  2019-02-19       Impact factor: 2.692

2.  Prophylactic use of dural tenting sutures in elective craniotomies in adults-is it necessary? A study protocol for a multicentre, investigator- and participant-blinded randomised, parallel-group, non-inferiority trial.

Authors:  Przemysław Kunert; Łukasz Przepiórka; Jan Fortuniak; Karol Wiśniewski; Ernest Jan Bobeff; Patrycja Larysz; Rafał Kruk; Bartłomiej Kulesza; Dariusz Szczepanek; Piotr Ładziński; Jarosław Żyłkowski; Sławomir Kujawski; Kamila Łabędzka; Dariusz Jaskólski; Radosław Rola; Tomasz Trojanowski; Andrzej Marchel
Journal:  Trials       Date:  2021-04-12       Impact factor: 2.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.